Omada Health, Inc. 8-K

What Happened
Omada Health, Inc. (OMDA) filed an 8-K reporting the results of its 2026 Annual Meeting of Stockholders. Sean Duffy and Trevor Fetter were elected as Class I directors to serve until the 2029 annual meeting, and stockholders ratified Deloitte & Touche LLP as the company’s independent registered public accounting firm for the fiscal year ending December 31, 2026. The record date for voting was April 20, 2026.

Key Details

• Director elections: Sean Duffy — 18,540,089 votes for, 9,134,162 withheld, 13,920,625 broker non-votes; Trevor Fetter — 18,538,042 for, 9,136,209 withheld, 13,920,625 broker non-votes. Both were elected to serve until the 2029 annual meeting.
• Auditor ratification: Deloitte & Touche LLP — 41,550,689 for, 16,905 against, 27,282 abstained; there were no broker non-votes on this proposal.
• Filing date / signature: Form 8-K filed June 16, 2026, signed by Sean Duffy, Chief Executive Officer.

Why It Matters

• Board continuity: Re-election of two Class I directors (including CEO Sean Duffy) confirms current leadership and governance direction through 2029.
• Auditor ratification: Stockholder approval of Deloitte provides continuity in external financial oversight for FY 2026.
• Voting mix: The presence of substantial broker non-votes on the director items (13.9M shares) and withheld votes indicates some investor abstention on director contests; investors watching governance or shareholder alignment should note these vote totals.